| Literature DB >> 27383700 |
Juliane Maria Guerreiro-Tanomaru1, Fernando Antonio Vázquez-García1, Roberta Bosso-Martelo1, Maria Inês Basso Bernardi2, Gisele Faria1, Mario Tanomaru1.
Abstract
OBJECTIVE: Mineral Trioxide Aggregate (MTA) is a calcium silicate cement composed of Portland cement (PC) and bismuth oxide. Hydroxyapatite has been incorporated to enhance mechanical and biological properties of dental materials. This study evaluated physicochemical and mechanical properties and antibiofilm activity of MTA and PC associated with zirconium oxide (ZrO2) and hydroxyapatite nanoparticles (HAn).Entities:
Mesh:
Substances:
Year: 2016 PMID: 27383700 PMCID: PMC5022225 DOI: 10.1590/1678-775720150422
Source DB: PubMed Journal: J Appl Oral Sci ISSN: 1678-7757 Impact factor: 2.698
Figure 1Evaluated materials and powder/liquid proportions
Mean values and standard deviation for initial and final setting time (minutes), compressive strength (MPa) after 24 hours and 21 days and radiopacity (mmAl)
| Setting time | Setting time | Compressive strength | Compressive strength | Radiopacity | |
|---|---|---|---|---|---|
| Initial | Final | 24 hours | 21 days | ||
| MTA | 23.67 (± 3.44)a | 170.7 (± 5.39)d | 19.63 (± 2.16)a | 29.51 (± 4.58)b | 4.52 (± 0.37)a |
| PC+ZrO2 | 42.00 (± 4.05)b | 151.8 (± 8.97)c | 23.29 (± 3.23)a | 45.77 (±2.73)a | 3.70 (± 0.07)b |
| PC+ZrO2+HAn10% | 40.33 (± 3.67)b | 100.5 (± 3.08)a | 14.41 (± 3.20)b | 30.90 (± 5.32)b | 4.18 (± 0.29)a |
| PC+ZrO2+HAn20% | 40.17 (± 3.06)b | 119.2 (± 9.28)b | 4.94 (± 1.48)c | 19.76 (± 1.94)c | 3.54 (± 0.20)b |
Equal letters in the same column indicate statistical similarity (p>0.05)
Mean values (%) and standard deviation for solubility and pH evaluation (2- and 7-day setting), after 15 hours of immersion
| Solubility | Solubility | pH | pH | |
|---|---|---|---|---|
| 2 days (%) | 7 days (%) | 2 days | 7 days | |
| MTA | 3.70 (± 0.91)a | 5.54 (± 1.22)a | 10.99 (±0.07)b | 10.54 (±0.37)b |
| PC+ZrO2 | 3.49 (± 0.47)a | 5.97 (± 1.32)a | 11.3 (±0.10)a | 10.87 (±0.14)a |
| PC+ZrO2+HAn10% | 5.96 (± 1.18)b | 7.91 (± 1.17)b | 11.3 (±0.11)a | 11.06 (±0.11)a |
| PC+ZrO2+HAn20% | 6.45 (± 1.15)b | 7.63 (± 1.39)b | 11.38 (±0.06)a | 10.87 (±0.29)a |
| Control | 7.45 (±0.09)c | 7.29 (±0.20)c |
Equal letters in the same column indicate statistical similarity (p>0.05)
Mean values (CFU mL-1) and standard deviation for antibiofilm activity evaluation
| 2 days | 2 days | 7 days | 7 days | |
|---|---|---|---|---|
| 5 hours | 15 hours | 5 hours | 15 hours | |
| MTA | 6.11 (±0.58)b | 6.50 (±0.66)b | 5.75 (±0.15)a | 5.65 (±0.38)a |
| PC+ZrO2 | 6.39 (±0.36)b | 6.71 (±0.22)b | 6.31 (±0.36)ab | 5.38 (±0.36)a |
| PC+ZrO2+HAn10% | 5.79 (±0.12)ab | 4.99 (±0.20)a | 5.96 (±0.38)a | 5.35 (±0.43)a |
| PC+ZrO2+HAn20% | 5.37 (±0.33)a | 5.44 (±0.26)a | 6.02 (±0.56)a | 5.35 (±0.34)a |
| Control | 7.11 (±0.35)c | 7.73 (±0.89)c | 6.76 (±.53)b | 6.91 (±0.36)b |
Equal letters in the same column indicate statistical similarity (p>0.05)